GlassScriptPhysician profile
Brock J Cookman
NPI 1427286681
$782,443.37
in general payments reported to CMS, 2019-2025
27 companies · $95K in 2025
The $95K reported for 2025 was more than what 99% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,157 · 2020: $2,214 · 2021: $32K · 2022: $156K · 2023: $334K · 2024: $156K · 2025: $95K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $473K · Travel and Lodging: $72K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $28K · Food and Beverage: $11K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $472,543.13 |
| Travel and Lodging | $72,437.84 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27,521.38 |
| Food and Beverage | $11,228.51 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,650.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $742,305.87 | 2019-2025 | Amplatzer Amulet, Optis, Dragonfly Opstar |
| Siemens Medical Solutions USA, INC. | $30,247.87 | 2024-2025 | Acuson Origin Diagnostic Ultrasound System, Acuson Sc2000 Diagnostic Ultrasound System |
| Boston Scientific Corporation | $2,800.25 | 2019-2025 | Spaceoar Vue System - 10ml |
| Edwards Lifesciences Corporation | $1,506.87 | 2019-2022 | |
| Abiomed | $1,450.77 | 2019-2025 | Impella |
| Medtronic, INC. | $1,373.76 | 2021-2025 | Corevalve Evolut R, Complete Se Vascular |
| Medtronic Vascular, INC. | $912.30 | 2019-2020 | |
| Cardiovascular Systems INC. | $494.88 | 2019-2022 | |
| Inari Medical, INC. | $283.83 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cathworks, INC. | $181.26 | 2022 | |
| Shockwave Medical, INC | $137.73 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $88.23 | 2020-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $85.94 | 2019-2025 | Lifevest |
| Philips North America LLC | $81.30 | 2022 | |
| Ge Healthcare | $77.17 | 2023 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surmodics, INC. | $65.60 | 2024 | Pounce Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy |
| Chiesi USA, INC. | $60.83 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $58.77 | 2021-2025 | |
| Stryker Corporation | $41.12 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Saranas, INC. | $40.31 | 2022 | |
| Biosense Webster, INC. | $38.09 | 2022 | |
| Pfizer INC. | $34.54 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $28.59 | 2025 | Camzyos |
| Regeneron Healthcare Solutions, INC. | $21.73 | 2022 | |
| W. L. Gore & Associates, INC. | $12.63 | 2019 | |
| Amgen INC. | $11.87 | 2021 | |
| Asahi Intecc USA, INC. | $1.26 | 2024 | Peripheral Vascular |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brock Cookman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.